Beyond its role in immune suppression, AXL is also implicated in EMT and cancer stemness, suggesting that inhibiting AXL could provide insights into these processes in metastatic disease and their impact on chemosensitivity and resistance. The gene discussed is AXL; the disease is metastatic neoplasm.